Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$173,750,511
+$117,010,223 QoQ
Shares Held
2,988,999
+206.1% QoQ
Ownership
2.01%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#12
of 329 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. PCVX ranks #29 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in PCVX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $173,750,511 | 2,988,999 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $56,740,288 | 976,429 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $54,230,140 | 1,175,339 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $60,819,157 | 1,688,483 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $103,064,729 | 3,170,247 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $133,746,183 | 3,542,007 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $324,735,017 | 3,966,956 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $510,345,474 | 4,466,137 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $239,605,839 | 3,173,167 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $216,964,923 | 3,176,181 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $168,167,221 | 2,677,822 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $123,251,898 | 2,417,652 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $109,487,556 | 2,192,382 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,200,409 | 32,028 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,451,350 | 30,268 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $205,224 | 8,551 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $303,073 | 13,928 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $306,898 | 12,708 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $275,511 | 11,581 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $314,105 | 12,381 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $232,730 | 10,339 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||